Abstract: PURPOSE: Local breast cancer relapse after breast-saving surgery and radiotherapy is associated with increased risk of distant metastasis formation. The mechanisms involved remain largely elusive. We used the well-characterized 4T1 syngeneic, orthotopic breast cancer model to identify novel mechanisms of postradiation metastasis. EXPERIMENTAL DESIGN: 4T1 cells were injected in 20 Gy preirradiated mammary tissue to mimic postradiation relapses, or in nonirradiated mammary tissue, as control, of immunocompetent BALB/c mice. Molecular, biochemical, cellular, histologic analyses, adoptive cell transfer, genetic, and pharmacologic interventions were carried out. RESULTS: Tumors growing in preirradiated mammary tissue had reduced angiogenesis and were more hypoxic, invasive, and metastatic to lung and lymph nodes compared with control tumors. Increased metastasis involved the mobilization of CD11b(+)c-Kit(+)Ly6G(high)Ly6C(low)(Gr1(+)) myeloid cells through the HIF1-dependent expression of Kit ligand (KitL) by hypoxic tumor cells. KitL-mobilized myeloid cells homed to primary tumors and premetastatic lungs, to give rise to CD11b(+)c-Kit(-) cells. Pharmacologic inhibition of HIF1, silencing of KitL expression in tumor cells, and inhibition of c-Kit with an anti-c-Kit-blocking antibody or with a tyrosine kinase inhibitor prevented the mobilization of CD11b(+)c-Kit(+) cells and attenuated metastasis. C-Kit inhibition was also effective in reducing mobilization of CD11b(+)c-Kit(+) cells and inhibiting lung metastasis after irradiation of established tumors. CONCLUSIONS: Our work defines KitL/c-Kit as a previously unidentified axis critically involved in promoting metastasis of 4T1 tumors growing in preirradiated mammary tissue. Pharmacologic inhibition of this axis represents a potential therapeutic strategy to prevent metastasis in breast cancer patients with local relapses after radiotherapy. Clin Cancer Res; 18 (16) 
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Translational relevance
Patients with local breast cancer relapse after conservative breast cancer surgery and radiotherapy have an increased risk of metastasis formation. To date there is no effective therapy to prevent progression to metastasis in these patients. Using a well- 
Introduction
Adjuvant radiotherapy provides survival advantages compared to surgery alone and it is nowadays standard treatment in the management of several cancers, including breast cancer (1) . Despite progress in the delivery mode, loco-regional post-radiotherapy relapses still occur in a fraction of treated patients. Relapses occurring within a pre-irradiated area are associated with an increased risk of local invasion, metastasis formation and poor prognosis compared to relapses occurring outside of the irradiated area including in breast (2) and head and neck cancers (3) .
Experimental evidence supports these clinical observations. In murine xenograft models, tumors developing within pre-irradiated beds are more invasive and metastatic compared to tumors growing outside irradiated beds, a condition also referred to as tumor bed effect (4, 5) . One common feature of the tumor bed effect is the appearance of hypoxia (6) (7) (8) , which is likely due to the inhibition of angiogenesis by ionizing radiations (9, 10) . Tumor hypoxia is associated with increased invasiveness, greater risk of metastasis formation and shorter disease-free survival in different human tumors, including soft tissue sarcoma (11), head and neck (12), cervical (13) and breast cancers (14) . In spite of its clinical relevance, the cellular and molecular mechanisms underlying the tumor bed effect are still not fully elucidated.
Using human melanoma cells grafted in pre-irradiated, immunosuppressed mice, Rofstad and colleagues demonstrated that interleukin-8 (IL-8) and the receptor of urokinase-type plasminogen activator (uPAR) are important mediators of the tumor bed effect in this model (8, 15 ) . We have previously shown that the matricellular protein cysteine rich protein 61 (CYR61) and integrin αVβ5 cooperate to promote invasion and metastasis of squamous cell carcinoma and colorectal adenocarcinoma growing subcutaneously in pre-irradiated, immunosuppressed mice (7).
Research. KitL/c-Kit axis promotes breast cancer metastasis 6 Kit ligand (KitL), also known as stem cell factor (SCF) or Steele factor, is a cell surface protein existing in two alternatively spliced isoforms (16) . One isoform contains a cleavage site that allows protease-mediated shedding from the cell surface as homodimeric soluble KitL, while the other one cannot be released and remains associated to the cell surface (17) . KitL binds to the tyrosine kinase receptor c-Kit (18) . During development KitL and c-Kit play critical roles in guiding cell migration, in particular at sites of hematopoiesis, in the central nervous system, in the gut and in the skin (melanogenesis) (19) . C-Kit is down-regulated in adult tissues, except in hematopoietic stem/progenitor cells in the bone marrow, in melanocytes and in mast cells. Accordingly, after development the KitL/c-Kit axis is essential for the maintenance of hematopoiesis and for mast cell survival and function in peripheral tissues (20) . In cancer c-Kit acts as oncogene in several tumors, in particular gastrointestinal stromal tumors (GIST), mastocytosis and melanoma (20) , through activating mutations in the extracellular or intracellular domain (18) , or through an autocrine KitL/c-Kit loop (21) . The KitL also activates tissue-resident mast cells to generate a tumor-promoting angiogenic microenvironment (22, 23) . A role of the KitL/c-Kit axis in metastasis formation, however, has remained unexplored.
In this work we investigated cellular and molecular mechanisms underlying the tumor bed effect in breast cancer by using a model mimicking local relapse after radiotherapy. Presented results identify the KitL/c-Kit axis as a previously unsuspected mediator of metastasis in breast cancer. Staining and acquisition were done as described (25) . Samples were acquired with a Fig. S1A ). Tumors growing in a pre-irradiated mammary tissue showed reduced microvascular density, increased hypoxia and necrosis (Fig. 1A) , consistent with radiation-induced inhibition of angiogenesis (9, 10). They were also more invasive into the surrounding muscle and fat tissues (Fig. 1B) , and more metastatic to ipsilateral axillary lymph nodes (Fig. 1C) , lungs ( Fig. 1D) and liver (Supplementary Fig. S1B ).
These results demonstrate that 4T1 breast tumors growing in a pre-irradiated mammary tissue undergo a tumor bed effect that recapitulates clinically relevant features of breast cancers locally relapsing after radiotherapy. 2D and Supplementary Fig. S2E ).
These results demonstrate that mammary tissue irradiation enhances recruitment of CD11b + cells contributing to lung metastasis formation. and activity of the HIF1 inhibitor NSC-134754 (30) (Supplementary Fig. S3A and   S3B ). Inhibition of HIF1 in 4T1 cells by NSC-134754 and genetic deficiency of the β subunit of the HIF complex in HEPA1 cells prevented hypoxia-induced up-regulation of KitL mRNA and protein (Fig. 3A, Supplementary Fig. S3B and S3C ). 4T1 tumors growing within a pre-irradiated bed had increased KitL protein (Fig. 3B ) and mRNA ( Supplementary Fig. S4A ) levels, and this increase was blunted by NSC-134754 treatment (Fig. 3B) . Mammary tissue irradiation alone did not induce KitL expression (Supplementary Fig. S4B ). Plasma levels of KitL were higher in pre-irradiated tumorbearing mice compared to controls (Fig. 3C ) demonstrating systemic release of KitL (31) . In contrast, CXCL12, a chemokine previously reported to promote CD11b Fig. S4D and S4E ) suppressed lung metastasis formation of 4T1 tumors growing in pre-irradiated mammary tissue (Fig. 3D) , while it did not affect 4T1 tumor cell growth in vitro or in vivo ( Supplementary Fig. S4F and S4G ).
HIF1-dependent
These results demonstrate that KitL expression is induced by hypoxia in a HIF1-dependent manner, and that KitL is required for increased metastatic spreading, but not primary growth, of 4T1 tumors implanted in pre-irradiated mammary tissue. Fig. S5B ). Their morphology was consistent with young, immature myeloid cells (Supplementary Fig. S5C ).
Circulating c-Kit + cells were unable to form hematopoietic colonies, in contrast to bone marrow-derived c-Kit + cells (Supplementary Fig. S5D ). Further phenotypical analysis revealed that circulating c-Kit in a significantly reduced increase in lung metastasis (Fig. 6A) . No effects on primary tumor growth were observed ( Supplementary Fig. S7B ).
These results indicate that mobillized CD11b Fig. S8E ).
These results demonstrate that c-Kit activity is critically involved in mediating the mobilization of CD11b are based on one breast cancer cell line only, 4T1. This line is known to induce an unusually strong mobilization of MDSC, which may not occur in all breast cancer models. It will also be important to ascertain whether in human breast cancer this mechanism is common to all breast cancer types, or whether it is specific for a particular breast cancer subtype. To this purpose we are interrogating additional experimental breast cancer models and initiating a clinical study to monitor the frequency of circulating CD11b 
